These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3001524)

  • 1. Cellular sodium transport in essential hypertension.
    Hilton PJ
    N Engl J Med; 1986 Jan; 314(4):222-9. PubMed ID: 3001524
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic and environmental factors influencing cellular sodium transport in essential hypertension.
    Hilton PJ
    J Clin Hypertens; 1986 Jun; 2(2):109-13. PubMed ID: 2428945
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for a circulating Na,K-pump inhibitor in essential hypertension.
    Hilton PJ
    Scand J Clin Lab Invest Suppl; 1986; 180():65-71. PubMed ID: 3012764
    [No Abstract]   [Full Text] [Related]  

  • 4. The relation of the natriuretic hormone to essential hypertension.
    de Wardener HE; MacGregor GA
    Postgrad Med J; 1983; 59 Suppl 2():74-7. PubMed ID: 6310538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium transport by leucocytes and erythrocytes in hypertensive subjects and their normotensive relatives.
    Gray HH; Johnson VE; Poston L; Hilton PJ
    J Hypertens Suppl; 1984 Dec; 2(3):S467-9. PubMed ID: 6599701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The polymorphism of red cell Na and K transport in essential hypertension: findings, controversies, and perspectives.
    Canessa M
    Prog Clin Biol Res; 1984; 159():293-315. PubMed ID: 6382325
    [No Abstract]   [Full Text] [Related]  

  • 7. Individual variability in membrane sodium transport during salt loading--evidence against the production of a Na+-K+-ATPase inhibitor in hypertension.
    Maling TJ; Siebers RW
    Prog Biochem Pharmacol; 1988; 23():91-100. PubMed ID: 2847194
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphocyte sodium efflux in normotensive and borderline hypertensive subjects with and without heredity for hypertension.
    Pedersen KE; Nielsen JR; Klitgaard NA; Jest P; Johansen T
    Scand J Clin Lab Invest Suppl; 1986; 180():101-3. PubMed ID: 3012759
    [No Abstract]   [Full Text] [Related]  

  • 9. Red-cell sodium-lithium countertransport and essential hypertension.
    Aronson PS
    N Engl J Med; 1982 Jul; 307(5):317. PubMed ID: 7088092
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of exogenous factors in alterations of red cell Na+-Li+ exchange and Na+-K+ cotransport in essential hypertension, primary hyperaldosteronism, and hypokalemia.
    Duhm J; Behr J
    Scand J Clin Lab Invest Suppl; 1986; 180():82-95. PubMed ID: 3012766
    [No Abstract]   [Full Text] [Related]  

  • 11. Membrane transport of ions in hypertension: a review.
    Heagerty AM; Riozzi A; Brand SC; Bing RF; Thurston H; Swales JD
    Scand J Clin Lab Invest Suppl; 1986; 180():54-64. PubMed ID: 3012763
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal sodium handling and sodium transport inhibitor in salt-sensitive essential hypertension.
    Iwaoka T; Umeda T; Miura F; Inoue J; Sasaki M; Naomi S; Sato T
    J Hypertens; 1991 Jan; 9(1):49-54. PubMed ID: 1848259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of changes in dietary sodium intake on normotensive subjects with and without a genetic predisposition to essential hypertension.
    Weissberg PL; West MJ; Wilkins MR; Kricka LJ
    J Hypertens Suppl; 1984 Dec; 2(3):S511-3. PubMed ID: 6100752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red-cell lithium-sodium countertransport and renal lithium clearance in hypertension.
    Weder AB
    N Engl J Med; 1986 Jan; 314(4):198-201. PubMed ID: 3941708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of ouabain-insensitive red blood cell cation transport in obese children.
    Urbino A; Dianzani I; Boero R; Guarena C; Quarello F; Cerutti F
    Boll Soc Ital Biol Sper; 1985 Jun; 61(6):825-8. PubMed ID: 2996571
    [No Abstract]   [Full Text] [Related]  

  • 16. Raised sodium pump activity and a circulating sodium transport inhibitor demonstrated on red blood cells of patients with untreated essential hypertension: correlation of pump activity with potassium permeability.
    Skrabal F; Hamberger L; Cerny E; Schönegger J; Gernhold M
    Klin Wochenschr; 1985; 63 Suppl 3():117-21. PubMed ID: 2987607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Erythrocyte Na+/H+ exchange and arterial hypertension].
    Semplicini A; Ceolotto G; Marzola M
    G Ital Cardiol; 1991 Dec; 21(12):1311-9. PubMed ID: 1667919
    [No Abstract]   [Full Text] [Related]  

  • 18. [Circulating inhibitor of the Na+-K+ pump in essential hypertension. Physiological and pharmacological variations].
    Pernollet MG; de Thé H; Delva P; Wauquier I; Devynck MA; Baudouin-Legros M; Deray G; Rosenfeld J; Meyer P
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1283-7. PubMed ID: 6098238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arterial pressure and the natriuretic hormone.
    de Wardener HE
    Scott Med J; 1984 Apr; 29(2):120-4. PubMed ID: 6099612
    [No Abstract]   [Full Text] [Related]  

  • 20. Active transport of sodium and potassium ions: mechanism, function, and regulation.
    Sweadner KJ; Goldin SM
    N Engl J Med; 1980 Apr; 302(14):777-83. PubMed ID: 6243739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.